Effect of Voxel Position on Single-Voxel MR Spectroscopy Findings

References

1. ↵
   Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172:541-548

   CrossRefPubMedWeb of Science
2. Arnold DL, Shoubridge EA, Villemure JG, Feindel W. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo: preliminary observations on tumor grading. NMR Biomed 1990;3:184-189

   CrossRefPubMed
3. Luyten PR, Marien AJ, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176:791-799

   CrossRefPubMedWeb of Science
4. Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177:633-641

   CrossRefPubMedWeb of Science
5. Demaerel P, Johannik K, Van Hecke P, et al. Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991;15:67-76

   CrossRefPubMed
6. Frahm J, Bruhn H, Hanicke W, Merboldt KD, Mursch K, Markakis E. Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. J Comput Assist Tomogr 1991;15:915-922

   CrossRefPubMed
7. Kugel H, Heindel W, Ernestus RI, Bunke J, du Mesnil R, Friedmann G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-709

   CrossRefPubMedWeb of Science
8. ↵
   Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752

   CrossRefPubMedWeb of Science
9. Mc Bride DQ, Miller BL, Nikas DL, et al. Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 1995;44:137-144

   CrossRefPubMedWeb of Science
10. ↵
    Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16:1593-1603

    Abstract
11. ↵
    Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1-15

    PubMedWeb of Science
12. Tien RD, Lai PH, Smith JS, Lazeyras F. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJR Am J Roentgenol 1996;167:201-209

    CrossRefPubMedWeb of Science
13. Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323-325

    CrossRefPubMedWeb of Science
14. Shimizu H, Kumabe T, Tominaga T, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:737-747

    Abstract
15. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686

    CrossRefPubMed
16. Remy C, Grand S, Lai ES, et al. 1H MRS of human brain abscesses in vivo and in vitro. Magn Reson Med 1995;34:508-514

    PubMed
17. Harada M, Tanouchi M, Miyoshi H, Nishitani H, Kannuki S. Brain abscess observed by localized proton magnetic resonance spectroscopy. Magn Reson Imaging 1994;12:1269-1274

    CrossRefPubMed
18. Tzika AA, Ball WS Jr, Vigneron DB, Dunn RS, Kirks DR. Clinical proton MR spectroscopy of neurodegenerative disease in childhood. AJNR Am J Neuroradiol 1993;14:1261-1281
19. Moats RA, Shonk T. Evaluation of automated MR spectroscopy: application in Alzheimer's disease. AJNR Am J Neuroradiol 1995;16:1779-1782

    Abstract
20. Kreis R, Farrow N, Ross BD. Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy: analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991;4:109-116

    CrossRefPubMedWeb of Science
21. Chang L, Miller BL, Mc Bride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995;197:525-531

    CrossRefPubMedWeb of Science
22. Chinn RJ, Wilkinson ID, Hall-Craggs MA, et al. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology 1995;197:649-654

    CrossRefPubMedWeb of Science
23. ↵
    Yousem DM, Lenkinski RE, Evans S, et al. Proton MR spectroscopy of experimental radiation-induced white matter injury. J Comput Assist Tomogr 1992;16:543-548

    PubMed
24. Usenius T, Usenius JP, Tenhunen M, et al. Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys 1995;33:719-724

    CrossRefPubMedWeb of Science
25. Heesters MA, Kamman RL, Mooyaart EL, Go KG. Localized proton spectroscopy of inoperable brain gliomas: response to radiation therapy. J Neurooncol 1993;17:27-35

    CrossRefPubMed
26. Szigety SK, Allen PS, Huyser-Wierenga D, Urtaasun RC. The effect of radiation on normal human CNS as detected by NMR spectroscopy. Int J Radiat Oncol Biol Phys 1993;25:695-701

    CrossRefPubMedWeb of Science
27. Sijens PE, Vecht CJ, Levendag PC, Van Dijk P, Oudkerk M. Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer: unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. Invest Radiol 1995;30:738-744

    CrossRefPubMed
28. Bizzi A, Movsas B, Tedeschi G, et al. Response of non-Hodgkin lymphoma to radiation therapy: early and long term assessment with H-1 MR spectroscopic imaging. Radiology 1995;194:271-276

    CrossRefPubMed
29. ↵
    Gober JR. Noninvasive tissue characterization of brain tumors and radiation therapy using magnetic resonance spectroscopy. Neuroimaging Clin N Am 1993;3:779-802
30. Taylor JS, Langston JW, Reddick WE, et al. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 1996;36:1251-1261

    CrossRefPubMed
31. Wald LL, Nelson SJ, Day MR, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 1997;87:525-534

    CrossRefPubMedWeb of Science
32. Kinoshita K, Tada E, Matsumoto K, Asari S, Ohmoto T, Itoh T. Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachytherapy. AJNR Am J Neuroradiol 1997;18:1753-1761

    Abstract
33. Esteve F, Rubin C, Grand S, Kolodie H, Le Bas JF. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys 1998;40:279-286

    CrossRefPubMedWeb of Science
34. ↵
    Burger PC, Heinz ER, Shibata T, Kleihaus P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 1988;68:698-704

    CrossRefPubMedWeb of Science
35. Burger PC, Kleihaus P. Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 1989;63:2014-2023

    CrossRefPubMedWeb of Science
36. Howells SL, Maxwell RJ, Griffiths JR. Classification of tumour 1H NMR spectra by pattern recognition. NMR Biomed 1992;5:59-64

    CrossRefPubMedWeb of Science
37. De Stefano N, Caramanos Z, Preul MC, Francis G, Antel JP, Arnold DL. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 1998;44:273-278

    CrossRefPubMedWeb of Science
38. Rand SR, Prost R, Haughton V, et al. Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from non-neoplastic brain lesions. AJNR Am J Neuroradiol 1997;18:1695-1704

    Abstract
39. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52

    PubMedWeb of Science
40. Miller BL, Chang L, Booth R, et al. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996;58:1929-1935

    CrossRefPubMedWeb of Science
41. Chang L, Mc Bride D, Miller BL, et al. Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. J Neuroimaging 1995;5:157-163

    PubMed
42. ↵
    Burger PC, Scheithauer BW. Tumors of the central nervous system. In: Rosai J, ed Atlas of Tumor Pathology Third series, fascicle 10. Washington, DC: Armed Forces Institute of Pathology 1994:25-77
43. ↵
    Burger PC, Kleihues P. Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 1989;63:2014-2023

    CrossRefPubMedWeb of Science
44. Paulus W, Peiffer J. Intratumoral histologic heterogeneity of gliomas: a quantitative study. Cancer 1989;64:442-447

    CrossRefPubMed
45. Glantz MJ, Burger PC, Herndon JE II, et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991;41:1741-1744

    Abstract/FREE Full Text
46. ↵
    Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH. Brain radiation lesions: MR imaging. Radiology 1986;158:149-155

    CrossRefPubMedWeb of Science
47. Mikhael MA. Radiation necrosis of the brain: correlation between, computed tomography, pathology and dose distribution. J Comput Assist Tomogr 1978;2:71-80

    CrossRefPubMed
48. Kingsley DPE, Kendall BE. CT of the adverse effects of therapeutic radiation of the central nervous system. AJNR Am J Neuroradiol 1981;2:453-460

    Abstract/FREE Full Text
49. van Dellen JR, Danziger A. Failure of computerized tomography to differentiate between radiation necrosis and cerebral tumour. S Afr Med J 1978;53:171-172

    PubMed
50. Valk PE, Dillon WP. Radiation injury of the brain. AJNR Am J Neuroradiol 1991;12:45-62

    Abstract/FREE Full Text
51. Ricci PE, Karis JP, Heiserman Fram EK, Bice AN, Drayer BP. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 1998;19:407-413

    Abstract
52. Kahn D, Follett KA, Bushnell DL, et al. Diagnosis of recurrent brain tumor: value of ²⁰¹Tl SPECT vs ¹⁸F-fluorodeoxyglucose PET. AJR Am J Roentgenol 1994;163:1459-1465

    CrossRefPubMed
53. Olivero WC, Dulebohn SC, Lister JR. The use of PET in evaluating patients with primary brain tumours: is it useful? J Neurol Neurosurg Psychiatry 1995;58:250-252

    Abstract/FREE Full Text
54. ↵
    Kuesel AC, Sutherland GR, Halliday W, Smith ICP. 1H MRS of high grade astrocytoma: mobile lipid accumulation in necrotic tissue. NMR Biomed 1994;7:149-155

    CrossRefPubMed
55. ↵
    Taylor JS, Reddick WE, Kingsley PB, Ogg RJ. Proton MRS after gadolinium contrast agent. Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance, In: Proceedings of the Society of Magnetic Resonance: Nice, France, August 19–25, 1995.
56. ↵
    Sijens PE, van den Bent MJ, Nowak PJCM, van Dijk P, Oudkerk M. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 1997;37:222-225

    PubMed
57. ↵
    Ricci PE, Schepkin VD, Elster AD, Hamilton CA. Effect of three gadolinium chelates on cerebral metabolite levels measured by single-voxel proton MR spectroscopy. In: Book of Abstracts, 37th Annual Meeting of the American Society of Neuroradiology, San Diego, CA, May 22–28, 1999. Oak Brook, IL: American Society of Neuroradiology; 1999